Consumers And Self-Medication: World Studies

8 September 1996

Studies conducted worldwide in the last year by the over-the-counter drug industry have found that consumers want clearer and more understandable wording on the labels of OTC products, according to Jerome Reinstein, director-general of the World Federation of Proprietary Medicine Manufacturers.

He told a Drug Information Association self-medication symposium in Mexico this summer that the world OTC drug market is predicted to climb from $37 billion today to $49 billion by 2000. At the WFPMM general assembly in 1991, 18 national studies of self-medication around the world were compared, while today there are over 30 such studies, both quantitative and qualitative.

The USA Nonprescription Drug Manufacturers Association has recently compiled 11 national consumer studies on self medication. These show that Americans treat over a third of their everyday health problems with OTCs, higher than the 23%-27% of minor ailments treated thus in other equally developed countries.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight